Business
ASTRAZENECA PRICES A $2BN BOND ISSUE
ASTRAZENECA PRICES A $2BN BOND ISSUE.
About this update from Astrazeneca Plc
[{"type":"text","content":"\n \nRNS Number : 2066H AstraZeneca PLC 06 June 2017 \n\n6 June 2017 07:00 BST\n \nASTRAZENECA PRICES A $2BN BOND ISSUE\n \nAstraZeneca PLC announces that, on 5 June 2017, it priced a three tranche Global bond offering totalling $2bn. The offering is expected to close on 12 June 2017, subject to customary closing conditions. AstraZeneca expects to use the net proceeds of the issue for general corporate purposes which may include the refinancing of existing indebtedness. The transaction, which is a global offering registered with the US Securities and Exchange Commission (SEC), consists of the following three tranches: \n \n· $1bn of 5 year fixed rate notes with a coupon of 2.375%;\n· $0.75bn of 10 year fixed rate notes with a coupon of 3.125%; and\n· $0.25bn of 5 year floating rate notes.\n \nBarclays, BofA Merrill Lynch, HSBC and Morgan Stanley acted as joint-bookrunning managers on the transaction. The notes will be issued under AstraZeneca's effective shelf registration statement on Form F-3, which AstraZeneca filed with the SEC on 22 November 2016. The offering is being made solely by means of the prospectus contained within that shelf registration statement, along with a prospectus supplement forming part of the effective registration statement, which investors should read.\n \nA copy of the prospectus supplement and accompanying prospectus relating to the offering can be obtained by contacting Barclays Capital Inc. c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone at 1-888-603-5847 or by email at [email protected]; HSBC Securities (USA) Inc., 452 Fifth Avenue, New York, NY 10018, Attention: Transaction Management Group, by telephone at 1-866-811-8049; Merrill Lynch, Pierce, Fenner & Smith Incorporated, NC1-004-03-43, 200 North College Street, 3rd floor, Charlotte NC 28255-0001, Attention: Prospectus Department, by telephone at 1-800-294-1322 or by email at [email protected]; or Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, NY 10014, by telephone at 1-866-718-1649 or by email at [email protected]. You may also download these documents for free by visiting ...